Beijing Hotgen Biotech Co Ltd
SSE:688068
Beijing Hotgen Biotech Co Ltd
SSE:688068
Price:
28.44 CNY
1.68%
Market Closed
Updated:
Apr 29, 2024
Section:
Relative Value
The Relative Value of one
Beijing Hotgen Biotech Co Ltd
stock under the Base Case scenario is
22.26
CNY.
Compared to the current market price of 28.44 CNY,
Beijing Hotgen Biotech Co Ltd
is
Overvalued by 22%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
22.26
CNY
Overvaluation 22%
Valuation Multiples
Multiples Across Competitors
Competitors Multiples
Beijing Hotgen Biotech Co Ltd Competitors
Beijing Hotgen Biotech Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Beijing Hotgen Biotech Co Ltd
SSE:688068
|
2.6B CNY | 2.7 | -25.5 | -12.9 | -12.9 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.8B USD | 5.2 | 37 | 22.8 | 33.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
182.6B USD | 4.2 | 22.6 | 16.5 | 20.3 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.6B USD | 2.8 | 31.4 | 17 | 26.2 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
38.1B CHF | 5.7 | 58.2 | 20 | 29.3 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
40.4B USD | 6 | 32.7 | 26.1 | 31.4 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
54.8T KRW | 14.8 | 63.9 | 33.7 | 48.5 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.7B USD | 7 | 33.8 | 23.6 | 26.3 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.5B USD | 9 | 44.6 | 30.5 | 36.5 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.4B USD | 3.1 | 41.5 | 17.6 | 27.5 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19.2B EUR | 7.1 | 75.4 | 32.4 | 53.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
